+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
COVID-19 Mitigation Products: Market Research, to 2024 - Product Thumbnail Image

COVID-19 Mitigation Products: Market Research, to 2024

  • Report
  • August 2020
  • 1020 Pages
From
From
From
From
From
From
From
Global Autoinjectors Market (3rd Edition), 2020-2030 - Product Thumbnail Image

Global Autoinjectors Market (3rd Edition), 2020-2030

  • Report
  • January 2020
  • 602 Pages
From
Loading Indicator
adroll